Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node+ Early Breast Cancer With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)

NCT05333328 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT05333328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05333328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node+ Early Breast Cancer With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)
Lead sponsor
Gangnam Severance Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
February 6, 2023
Completion date
January 31, 2033
Enrollment
418 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, estrogen receptor positive tumor, her2-negative breast cancer, node-positive breast cancer, premenopausal breast cancer